FINISHED DOSAGE FORMULATIONS
Drug : ARAVA
Dosage Form : TABLET; ORAL
Application Number : 20905
Country : US
Patented : No
Drug : TRICOR
Dosage Form : TABLET; ORAL
Application Number : 21656
Country : US
Patented : No
Drug : NEXICLON XR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 22500
Country : US
Patented : Yes
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 211571
Country : US
Patented : No
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
Drug : AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Dosage Form : TABLET; ORAL
Application Number : 203874
Country : US
Patented : No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77183
Country : US
Patented : No
Drug : LEVOFLOXACIN
Dosage Form : TABLET; ORAL
Application Number : 76710
Country : US
Patented : No
Drug : TRIGLIDE
Dosage Form : TABLET; ORAL
Application Number : 21350
Country : US
Patented : No
Drug : DEFERIPRONE
Dosage Form : TABLET; ORAL
Application Number : 208800
Country : US
Patented : No
Drug : LAMOTRIGINE
Dosage Form : TABLET; ORAL
Application Number : 78525
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
Application : Co-Processed Excipients
Excipient Details : Orally Disintegrating Tablets
MARKET PLACE
Reply
30 Sep 2021
REF. STANDARDS & IMPURITIES
LOOKING FOR A SUPPLIER?